Knee Implant Market | New Innovations, Mergers and Acquisitions, and Strategies

Knee implants are artificial bone and cartilage used in knee implantation that mimics the motion of a normal knee. These implant designs recognize the complexity of the joint. They are used to replace the damaged part of the knee during arthroplasty, a surgical procedure for knee implantation. They are made up of metal alloys, ceramic materials or strong plastic. Several orthopedic companies produce different types of implants used in knee replacement.

Growing Demand for Knee Replacement Procedures in Emerging Countries Such as China and India are Anticipated to Provide Opportunities for the Companies in the Knee Implant Market

The increase in geriatric population and rise in the population suffering from medical conditions including arthritis and osteoporosis are the major factors driving the global knee implant market. A large part of the population suffers from joint pains and other orthopedic conditions. Knee pain is one of the common complaints among the elderly population. It is the symptom of various medical conditions including osteoporosis, osteoarthritis and rheumatoid arthritis. Furthermore, increasing awareness about arthroplasty among patients and growing biocompatibility and durability of implants due to advancements in technology are some factors contributing to the growth of the global knee implant market. Additionally, factors such as growing investment by the major healthcare companies and the increasing number of initiatives by the government for improving healthcare scenario are also contributing to the growth of knee implant market. However, the high cost of knee implants and procedures are hampering the growth of the global knee implant market.

The Hospital Segment Among the End Users Dominated the Market with High Share in the Global Knee Implant Market

The global knee implant market is segmented based on procedure, component and end-user. The procedure segment is further categorized into total knee replacement, partial knee replacement and revision knee replacement. Total knee replacement procedure accounted for the largest share in the global knee implant market owing to its less complexity and high demand from professionals practicing the procedure. Based on components, the global knee implant market is further segmented into fixed-bearing prosthesis and mobile-bearing prosthesis. The end user segment is further classified into hospitals, orthopedic clinics and ambulatory surgical centers. The domination of the hospital segment is attributed to growing preference to hospitals for surgeries and increasing investment in hospitals.

North America Region Dominated the Global Knee Implant Market, Accounting for the Largest Share in the Market

Based on geography, the global knee implant market is divided into four major regions namely, North America, Europe, Asia-Pacific, and the Rest of the World. The large share of the region attributed to the increase in the geriatric population, availability of advanced technology, improved healthcare infrastructure and high awareness regarding knee replacement procedures. On the other hand, the knee implant market in the Asia Pacific region is anticipated to register the highest rate of growth. The fastest growth of the market in this region attributes to large population base suffering from severe knee pain, growing investment in the healthcare sector and the increasing number of government initiatives to improve health of the population.

The Major Healthcare Companies Are Opting for Mergers and Acquisitions Strategies to Increase their Sales

The global knee implant market is fragmented as many small-size companies compete with large size companies. The major players in the global knee implant market are B. Braun Melsungen, Arthrex GmbH, Johnson & Johnson, Smith & Nephew PLC., Stryker and  Zimmer Biomet; Corin Group, DePuy Synthes Companies, MicroPort Scientific Corporation, DJO Global and Exatech India Pvt Ltd. are among the other players. The latest acquisition in the market was witnessed during 2016 when Johnson and Johnson acquired DePuy.

For More Details@ https://bit.ly/2OjvWll 

Endoscopy Ultrasound: Industry Estimation

Endoscopy ultrasound or echo-endoscopy is combined endoscopy and ultrasound, used to obtain images and information of digestive tract, including esophagus, stomach, rectum, and colon, and for organs near the digestive tract, including gallbladder, pancreas, and liver. In Endoscopy procedure, long, thin tube is inserted into the patient’s mouth or rectum that contains a camera to see inside the body. Ultrasound uses high-frequency sound waves to make pictures of the internal body. Endoscopy ultrasound is used for Diagnosing cancers of the digestive tract and Diagnosing problems in the bile ducts and gallbladder.

High accuracy in diagnosis and treatment of gastrointestinal (GI) diseases have given rise to the adoption of endoscopy ultrasound techniques this, in turn, is driving the growth of Endoscopy Ultrasound Market. Increasing the prevalences of gastrointestinal cancers, including liver and pancreas, and other cancers and innovative and new product offering by the leading market players are the factors also driving the growth of the market. However, the lack of skilled professionals in the sector is expected to hamper the growth of Endoscopy Ultrasound Market. The Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and other healthcare agencies have set policies and regulations about the expertise of health care providers for performing endoscopy ultrasound procedures in any healthcare setting.

Among the geographies, North America holding a leading contributor in the endoscopy ultrasound market. The factors responsible for the growth of the market in this region are the availability of new and innovative product in the U.S. and growing the prevalence of gastrointestinal cancers. The rise in demand for new diagnostic tools for cancer and Adoption of adequate educational programs and Implementation of training regarding the endoscopy ultrasound procedures are expected to boost the market in Asia Pacific countries. Moreover, emerging countries such as China and India have adopted endoscopy ultrasound techniques as a diagnostic and therapeutic tool in cancer. Going forward, the growing the occurrence of gastrointestinal cancers is anticipated to be the highest growth Endoscopy Ultrasound Market over the upcoming years in the Asia Pacific.

                                                                                                                               View More >>>

Healthcare Journal | Orphan Drugs

Orphan drugs are medicinal products intended for diagnosis, prevention or treatment of life-threatening or very serious diseases or disorders that are rare. A disease or disorder is defined as rare in Europe when it affects less than 1 in 2,000 citizens. These drugs are called as orphan as pharmaceutical companies have small interest in developing and marketing these drugs as these are intended for only a small number of patients. For drug companies, the extremely high cost of bringing a medicinal product to market would not be recovered by the anticipated sales of such medicines. As a result the potential market for new drug treatment is also small and the drug companies industry would actually incur a financial loss.

These drugs are used to treat the population suffering from the very serious, but rare diseases for which no treatment available. There are around 25 to 30 million people are affected by this diseases in Europe. The awareness about the orphan drug is growing rapidly across the world that further leads to the growing adoption of orphan drug act in the japan, Australia, Europe and others countries to stimulate research and development in the orphan drug.

The orphan drug market segmented as diseases indication, product type, and distribution channels. The segment dieses type is further divided into sub segment including Oncology, Gastrointestinal, Pulmonary, Neurology, Hematology, Cardiovascular, Metabolic disorders, Endocrinology, Infectious diseases and other. The product type segment included Biological and Non-bio logical products and distributed over the channels like hospital pharmacy, retail pharmacy and others.

Economic incentives to encourage drug companies to develop and market medicines for rare disease treatment is the key driving factor in the orphan drug market. The rising occurrence of rare cancer cases, availability of orphan drugs at hospital pharmacy and increasing hospitalization treatment for rare diseases are expected to enhance the growth of orphan drug market over the forecast period. On the other hand, the cost associate with production and R&D is more as compare with other drugs that may hampering the market growth. Moreover, the rising awareness of rare disease among population and increasing investments in R&D is projected to create several opportunities in upcoming years.

For More Details@ https://bit.ly/2Pvk5we 

Obesity Surgery | Medical Instruments

Obesity has become an epidemic worldwide, it is not only restricted to any particular group of population. Several age group of people are in the grip of obesity. Nowadays, people are increasingly considering surgical weight loss method to get rid of obesity problem. Obesity surgeries are often called bariatric surgeries, these surgeries make use of a variety of obesity surgery devices. The global obesity surgery devices market has been observing remarkable growth since the past few years.

There are many factors which are indicating a positive outlook of market for medium and long term. Factors such as high incidences of obesity, changing food and working habit, and high consumption of fast food are major factor for the growth of obesity surgery devices market. Additionally, high healthcare expenditure, and increased awareness about obesity related risks among patients are promoting the growth of this market.

On the basis of region, the obesity surgery devices market is fragmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is the largest market for the obesity surgery device market, due to increasing demand for minimally invasive procedures for reducing obesity, high expenditure on healthcare and increasing prevalence of obesity in the region. The large market share of this segment can be attributed to the rapidly growing obese population and rise in the number of bariatric surgeries.

Asia Pacific region is fastest growing market among the regions during the forecast. The countries like China and India is most promising market, due to large population and rising incidence of obesity in Asian countries due to changing life style, changing consumption habits. Additionally, increasing demand for standardized world class medical facilities, increasing healthcare spending ability among people and government initiatives to provide better health facilities their nationals, are some major factors driving the high growth of this market in these regional segments.

For More Details: https://bit.ly/2Pn0ezs 

iBox Sciatica Small Animal Imaging System is Designed to Automate Your in Vivo Small Animal Imaging Research with One-Touch

Small animal imaging is a procedure employed using imaging devices and elements observing biological processes in animals such as rats and mice for drug genetic material expression studies. These devices are comparable to the devices that are used for diagnostic in humans owing to its smaller size, these devices are also referred to as micro devices. Imaging systems are cost-effective for commercialization and steady validation of new drugs as it contains the whole body scan of the animals. The examination provided by using this system can deliver respected information in preclinical or phase I stage of clinical trials and to recognize the activity of pharmaceutical compounds. Small animal imaging is measurement and allocation of biological processes that include the study of the target molecule that is used in clinical research for drug development.

The factors driving the growth of this market are technological advancements such as high-resolution multimodality MRI in the field of small animal imaging and an upsurge in market demand for small animal imaging techniques. Further, increasing number of the pre-clinical research, and growing investments in the development of medicines and are also boosting the growth of this market. Additionally, growing applications of in-vivo imaging in pre-clinical research, increasing number of Pharmaceutical companies and clinical research organizations, and real-time data storage and high-resolution modalities are again some of the key factors that are propelling the growth of the small animal imaging market. On the contrary, insufficient infrastructure provisions for research facilities, and the lack of skilled research staff in developing economies with the prerequisite of high-end devices are the major restraining factors for small animal imaging market.

In terms of geographies, North America has led the growth of this Small animal imaging market followed by Europe. While the Asia Pacific is the fastest growing region in this market. The growth in North America region is due to investments by clinical research organizations in pre-clinical studies, growing number of pharmaceutical and research-based organizations, promising compensation policies by originations and aggregate government funding in research activities are driving the growth in this market. Furthermore, in Europe region factors such as rising amount of research organizations for diagnosis of diseases and increasing investments by pharmaceutical companies in R&D are major factors boosting the growth of the small animal imaging market. Additionally, in the Asia Pacific region, the countries such as India and China are proposing high growth opportunities for the small animal imaging market players, increasing number of translational research activities and growing government support for biotechnology and pharmaceutical R&D are propelling the growth in this market.

iBox® Scientia™ Small Animal Imaging System from Analytik-Jena

October 2016, Analytik-Jena has launched iBox® Scientia™ Small Animal Imaging System. The iBox Scientia featured high sensitivity imaging and accurate quantification of bioluminescent and fluorescent sources. The new BioCam 900 camera provided superior imaging capabilities for bioluminescence. The system was versatile and supported imaging of any probe in the visible to near-infrared (NIR) range. NIR enabled less skin autofluorescence (~650nm) and deep penetration with use of RFP for (3X) 2 penetration depth and GFP, NIR for near (8X) 2 penetration depth. The wide spectrum also allowed more options for multiplex labeling. This capability displayed tissue/tissue interaction, enhanced signal to background ratio and detection of multiple fluorescent proteins or labels.

For More Details@ https://bit.ly/2PKBFxc

Hong Kong Researchers Develop Safer Alternative to Lead in X-Ray Shields

Medical Radiation shielding refers to a physical barrier that provides protection to the people from the harmful effects of exposure to ionizing radiation. It is based on the principle of reducing waves or rays affected by blocking or bouncing particles through a barrier material. Radiation shielding is used in the room interior, as radiotherapy suites and in shielded doors in hospitals. These radiotherapy suites are designed to protect medical patients and workers from exposure of direct or indirect radiation during diagnostic imaging in clinics, hospitals or another diagnostic center.

Factors such as rising use of nuclear medicine and radiation therapy for diagnosis and treatment purpose to trigger the growth of this market. Furthermore, increase in the number of diagnostic imaging centers due to growing frequency of chronic diseases such as cancer, prompt installation of radiology equipment, necessities of supporting accessories such as radiation shielding tools and other related equipment are also driving the growth of medical radiation shielding market.

Additionally, huge amount of ionizing radiation exposure can also lead to disturbing health impacts such as cancer, tumor and other severe side effects so as a result the necessity for protecting patients from harmful radiations while working under such conditions radiotherapy suites are designed. Moreover, increasing consciousness about safety while handling radio-active equipment is further estimated positive growth in medical radiation shielding market. In diagnostics centers having proper radiation shielding is significant in order to confirm the safety of its medical staff as well as of their patients. Strong growth in developing nations will create opportunities for the medical radiation shielding market.

In terms of geographies, North America will remain the most lucrative market for medical radiation shielding, followed by Europe. The Asia Pacific region is the fastest growing region in this market. In North America region factors such as rising frequencies of cancer and growing usage of nuclear medicine and radiation therapy for diagnosis and treatment are driving the growth in the North America region. In Asia Pacific region growing consciousness about radiation safety and cumulative funding in the healthcare sector is fuelling the growth of the medical radiation shielding market in this region.

Hong Kong Researchers Develop Safer Alternative to Lead in X-Ray Shields

April 2017, Polytechnic University researchers have created a safer, lighter X-ray shield by mixing the metal used in light bulb wires with a common plastic. The combination of tungsten and polyurethane offers 40 percent more protective than lead, which is conventionally used to protect people from radiation during X-ray procedures, yet it is 22 percent lighter.

“The material is non-toxic and can be recycled and processed into protective clothing,” said Fei Bin, associate professor at the university’s institute of textiles and clothing, who led the team.

For More Details @ https://bit.ly/2wu19pJ

Medical Gas and Equipment’s | Healthcare Journal Blog

Medical gases are considered as medical products and those equipment’s that can handle medical gases are termed as medical gas equipment’s. These are frequently used in healthcare by healthcare professionals for diagnostic and treatment of the patients. Additionally, it has varied usage in pharmaceutical and biotechnology industry, such as, pharmaceutical manufacturing, cell culture studies, and drug discovery and development. Commonly used medical gases are Medical air, Oxygen, Nitrous oxide, Nitrogen, Carbon dioxide etc.

Global medical gas and equipment’s market is showing a positive trend of development around the globe. There are many factors which are helping to boost this market such as rising incidence of chronic diseases, growing number of industry-friendly safety initiatives undertaken by the government, implementation of U.S. FDA safety and innovation act, growing base of geriatric population, and increasing demand for home healthcare and point of care products are some of the major factors propelling the growth of the medical gases market.

On the basis of region, the global medical gas and equipment’s market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). Due to presence of a well-established medical gases market, high prevalence of patients with respiratory disorders, and growing aging population have contributed to the large share of the North American region. However, the Asia-Pacific region is expected to grow at the highest CAGR; growth in this market can be attributed to increasing healthcare awareness, rising healthcare expenditures, growth in the aging population, and growth in per capita income.

For More Details@ https://bit.ly/2P4pH08

Development of Medical Videoscopes | Top Market Players | Market Estimation

Medical videoscopes is a type of equipment that is used to illuminate the body cavities to obtain internal body images in medical and surgical settings. The real-time images taken by videoscopes are displayed in front of surgeons during the medical examination or surgical procedure to enable them to have a clear idea of the patient’s medical condition.

Medical videoscopes are used across various applications such as endoscopy, gynecology, laparoscopy, arthroscopy, urology, and bronchoscopy. Apart from their diverse applications, the market for medical videoscopes is also gaining impetus from the latest technological advances introduced in endoscopic procedures, which in turn have resulted in several improvisations in videoscopes. Additionally, the rapidly rising geriatric population, which is more vulnerable to gastrointestinal and orthopedic diseases, is also anticipated to accelerate demand from the global medical videoscopes market. However, the high cost of this equipment may hinder several small and mid-sized hospitals from investing in them, subsequently hampering the overall growth of the market.

North America is the largest market for medical videoscopes market, due to increasing number of endoscopy training workshops and several initiatives take by the U.S. and Canada governments are augmenting the growth of the medical videoscopes market. For instance, Given Imaging developed an ingestible camera, named ‘the PillCam Colon’ that is approved by the U.S. Food and Drug Administration to be used during colonoscopy procedures.

Asia Pacific region, is developing at a great pace and is considered to be as the most promising market for the growth of medical videoscopes market due to the presence of a large population base, increasing health care expenditure by governments, rising research funding for better treatments of its people, growing awareness related to videoscopes procedures among patients, etc. are contributing to the growth of this market. Furthermore, increasing government support to set up modern healthcare infrastructure, favorable reimbursement scenario and various tax benefits would also drive the medical videoscopes market in the coming years.

For More Details@ https://bit.ly/2N8kOTj

Active Nutraceutical Ingredients Top Global Companies are Cargill, Dowdupont, BASF, ADM, Associated British Foods, DSM, Ingredion

Active nutraceuticals are products that provides protection against chronic disease as well as provides physiological benefit. Active nutraceuticals are used to improve health, delay the aging process, prevent chronic diseases, increase life expectancy, and support the structure or function of the body. The active nutraceutical ingredients can be consumed through various foods such as dietary supplements, functional foods, and functional beverages. The major application of nutraceutical ingredients is seen in dietary supplements segment.

Many factors are helping to boost this market, such as increasing health awareness among people, increasing demand for healthy food, growing aging population who want to remain active and fit for day to day work, memory enhancement, joint strengthening, growing trends of well being and vitality among youth population. In addition, customization of active nutraceuticals as per different requirements of different age group of people is also one of the key factor supporting the market growth. Furthermore, many companies are focusing on developing different variety of active nutraceuticals in order to improve the market growth.

North America dominates the global active nutraceuticals market. Asia pacific region is expected to grow at the highest CAGR during the forecast period of 2018-2024 due to growing number of health conscious young people, shifting trend from taking vitamin supplements to meet the RDA nutrition towards overall improvement of health, increasing self-medication among consumers, easily availability of these product through traditional and online medical stores, increasing disposable income among people in these regions etc. Are influencing the market growth rate in Asia-pacific region.

For More Details@ https://bit.ly/2nTUscT

Bosch Group announces its plans to divest its pharmaceutical packaging business, amid fear of competition from specialty SMEs.

An ongoing in-Pharma Technologist article noticed that German-based Bosch Group is looking its pharmaceutical and nourishment bundling innovation units. The portfolio incorporates single units, finish lines and coordinated frameworks for assembling and preparing both fluid and strong medications. It likewise contains programming answers for track and follow, process innovation, essential bundling, and the capacity to pack in a few styles including rankles, jugs, cases, and stick packs.

A representative from Bosch noted little and medium-sized undertakings are at an auxiliary preferred standpoint in the space, and the organization can’t contend. “Bosch is sure that its bundling innovation activities should be put on an alternate balance that will enable them to respond all the more adaptably to the particular prerequisites of bundling,” the representative said. The organization intends to locate a vital purchaser with a “reasonable idea for taking the business forward.”